skip to main content

CORPORATE PRESENTATION

We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.

DOWNLOAD OUR CORPORATE PRESENTATION
DOWNLOAD OUR QUARTERLY FACTSHEET

Quarterly Results

2025

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Fourth Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Third Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Second Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics First Quarter 2025 Factsheet PDF

2024

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Fourth Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Third Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2024 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2024 Financial Results Presentation PDF

2023

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2022

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2021

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2020

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing
 Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF

2019

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF

2018

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2017

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF

2016

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2016 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2015

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF

2014

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF

2013

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF

2012

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF

2011

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF

2010

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF

2009

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF

2008

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF

2007

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF

2006

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF

2005

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2005 Financial Results PDF
SEC Filing Form 10-K Link
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF

2004

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
view all view less

Press Releases

11 Mar 2026

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
The pivotal study of Tyvaso® (treprostinil) Inhalation Solution demonstrated a statistically significant preservation of lung function across all subgroups, as measured by absolute forced vital capacity (FVC), and fewer...
Download pdf

09 Mar 2026

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
Agreements for aggregate $1.5 billion Accelerated Share Repurchase (ASR) already executed, with an additional $500 million authorized within the next yearSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS...
Download pdf

03 Mar 2026

United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr.Martine Rothblatt,Chairperson and Chief Executive Officer, will provide a...
Download pdf

02 Mar 2026

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
The phase 3 ADVANCE OUTCOMES study of ralinepag met its primary endpoint and several important secondary endpoints, including increasing odds of clinical improvement by 47%, in predominantly pre-treated patients with...
Download pdf

25 Feb 2026

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter and year ended...
Download pdf

23 Feb 2026

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz,President and Chief Operating Officer, will provide a company...
Download pdf
view all

Events and presentations

09 Mar 2026

Leerink Global Healthcare Conference

01:00 PM ET

Listen to webcast

02 Mar 2026

TD Cowen Health Care Conference

02:30 PM ET

Listen to webcast

02 Mar 2026

Phase 3 ADVANCE OUTCOMES Clinical Trial Results

08:30 AM ET

Listen to webcast Download Presentation PDF

25 Feb 2026

United Therapeutics Fourth Quarter and Full Year 2025 Financial Results

09:00 AM ET

Listen to webcast Download Presentation PDF Download Fact Sheet PDF

12 Jan 2026

44th Annual J.P. Morgan Healthcare Conference

04:30 PM ET

Listen to webcast Download Presentation PDF

18 Nov 2025

Jefferies Global Healthcare Conference

07:00 AM ET

Listen to webcast
view all

SEC Filings

Corporate Annual Reports

PROXY STATEMENTS